Kevin Charles Oeffinger, MD

Professor of Medicine
Professor in the Department of Community and Family Medicine
Professor in Population Health Sciences
Member of the Duke Cancer Institute
Campus mail 2424 Erwin Dr, Suite 601, Duke Cancer Institute, Durham, NC 27705
Phone (919) 668-2122
Email address kevin.oeffinger@duke.edu

Kevin Oeffinger, MD, is a family physician, Professor in the Department of Medicine, and a member of the Duke Cancer Institute (DCI). He is founding Director of the DCI Center for Onco-Primary Care, and Director of the DCI Supportive Care and Survivorship Center. He has a long-standing track record of NIH-supported research in cancer screening and survivorship and has served in a leadership capacity in various cancer-focused and primary care-focused national committees and organizations, including the American Society of Clinical Oncology, the American Cancer Society, and the American Academy of Family Physicians. He is currently an Associate Editor for the Journal of the National Cancer Institute.

The three-fold mission of the DCI Center for Onco-Primary Care are are to: (1) deliver evidence-based, patient-centered, personalized health care across the cancer continuum by enhancing the interface between cancer specialists and primary care clinicians; (2) conduct innovative research with cutting-edge technology that can be translated to the community setting; and (3) train and educate the next generation of clinicians and researchers to extend this mission. 

Dr. Oeffinger's clinical expertise is managing survivors of pediatric and young adult cancer.

Education and Training

  • Advanced Research Training, Epidemiology And Genetics, Radiation Epidemiology, National Cancer Institute, 1999 - 2000
  • Family Medicine Academic Fellowship, Baylor College of Medicine, 1987 - 1988
  • Family Medicine Internship and Residency, Baylor College of Medicine, 1984 - 1987
  • M.D., University of Texas Health Science Center San Antonio, 1984

Publications

Chow, Eric J., Yan Chen, Gregory T. Armstrong, Laura-Mae Baldwin, Casey R. Cai, Todd M. Gibson, Melissa M. Hudson, et al. “Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer.” J Am Heart Assoc 11, no. 12 (June 21, 2022): e024735. https://doi.org/10.1161/JAHA.121.024735.

PMID
35674343
Full Text

Zullig, L. L., A. D. Sung, M. G. Khouri, S. Jazowski, N. P. Shah, A. Sitlinger, D. V. Blalock, et al. “Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review.” Jacc: Cardiooncology 4, no. 2 (June 1, 2022): 149–65. https://doi.org/10.1016/j.jaccao.2022.03.005.

Full Text

Williams, AnnaLynn M., Sedigheh Mirzaei Salehabadi, Mengqi Xing, Nicholas S. Phillips, Matthew J. Ehrhardt, Rebecca Howell, Yutaka Yasui, et al. “Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma.” Blood 139, no. 20 (May 19, 2022): 3073–86. https://doi.org/10.1182/blood.2021013167.

PMID
34861035
Full Text

Zullig, Leah L., Connor Drake, Mohammad Shahsahebi, Renee A. V. Avecilla, Colette Whitney, Coleman Mills, and Kevin C. Oeffinger. “Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review.” J Cancer Surviv, May 17, 2022. https://doi.org/10.1007/s11764-022-01212-0.

PMID
35578150
Full Text

Tonorezos, Emily S., Richard J. Cohn, Adam W. Glaser, Jeremy Lewin, Eileen Poon, Claire E. Wakefield, and Kevin C. Oeffinger. “Long-term care for people treated for cancer during childhood and adolescence.” Lancet 399, no. 10334 (April 16, 2022): 1561–72. https://doi.org/10.1016/S0140-6736(22)00460-3.

PMID
35430023
Full Text

Check, Devon K., Renee A. V. Avecilla, Coleman Mills, Michaela A. Dinan, Arif H. Kamal, Beverly Murphy, Salma Rezk, Aaron Winn, and Kevin C. Oeffinger. “Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies.” J Pain Symptom Manage 63, no. 4 (April 2022): e397–417. https://doi.org/10.1016/j.jpainsymman.2021.10.015.

PMID
34748896
Full Text

Blaes, A. H., S. Konety, J. Hui, K. Dusenbery, J. Yuan, S. Dent, K. C. Oeffinger, and L. M. Turcotte. “How to Treat Breast Cancer After Childhood Cancer: Management of Oncologic and Cardiovascular Concerns.” Jacc: Cardiooncology 4, no. 1 (March 1, 2022): 126–29. https://doi.org/10.1016/j.jaccao.2021.12.003.

Full Text

Yeh, Jennifer M., Kathryn P. Lowry, Clyde B. Schechter, Lisa R. Diller, Grace O’Brien, Oguzhan Alagoz, Gregory T. Armstrong, et al. “Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness.” J Natl Cancer Inst 114, no. 2 (February 7, 2022): 235–44. https://doi.org/10.1093/jnci/djab149.

PMID
34324686
Full Text

Pan, I-Wen, Kevin C. Oeffinger, and Ya-Chen Tina Shih. “Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening.” J Natl Cancer Inst 114, no. 2 (February 7, 2022): 254–62. https://doi.org/10.1093/jnci/djab150.

PMID
34320199
Full Text

Henderson, Tara O., Brynn W. Fowler, Haley A. Hamann, Paul C. Nathan, Jillian Whitton, Wendy M. Leisenring, Kevin C. Oeffinger, et al. “Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.” Cancer 128, no. 2 (January 15, 2022): 373–82. https://doi.org/10.1002/cncr.33922.

PMID
34606625
Full Text

Pages